| 论中药质量源于设计 |
| |
| 引用本文： | 徐冰,史新元,吴志生,张燕玲,王耘,乔延江. 论中药质量源于设计[J]. 中国中药杂志, 2017, 42(6): 1015-1024 |
| |
| 作者姓名： | 徐冰 史新元 吴志生 张燕玲 王耘 乔延江 |
| |
| 作者单位： | 北京中医药大学 中药信息工程研究中心, 北京 100029;北京市科委 中药生产过程控制与质量评价北京市重点实验室, 北京 100029;教育部中药制药与新药开发关键技术工程研究中心, 北京 100029,北京中医药大学 中药信息工程研究中心, 北京 100029;北京市科委 中药生产过程控制与质量评价北京市重点实验室, 北京 100029;教育部中药制药与新药开发关键技术工程研究中心, 北京 100029,北京中医药大学 中药信息工程研究中心, 北京 100029;北京市科委 中药生产过程控制与质量评价北京市重点实验室, 北京 100029;教育部中药制药与新药开发关键技术工程研究中心, 北京 100029,北京中医药大学 中药信息工程研究中心, 北京 100029,北京中医药大学 中药信息工程研究中心, 北京 100029,北京中医药大学 中药信息工程研究中心, 北京 100029;北京市科委 中药生产过程控制与质量评价北京市重点实验室, 北京 100029;教育部中药制药与新药开发关键技术工程研究中心, 北京 100029 |
| |
| 基金项目： | 国家自然科学基金青年基金项目（81403112）;国家自然科学基金重点项目（81430094）;国家中药标准化项目（ZYBZH-C-QIN-45） |
| |
| 摘 要： | 药品质量源于设计(quality by design,QbD),形成于生产过程,优化提高于生命周期。该文在回顾制药QbD发展历程的基础上,围绕质量设计、质量控制和质量改进详细解读了制药QbD实施方略。在分析中药研发和生产应用QbD难点和特点的基础上,提出中药QbD的"四全"模式,即全局设计、全息分析、全面控制和全程优化,体现了中药质量设计的系统观和整体观。在全局设计中,构建以临床疗效为导向和以多学科理论知识为基础的中药质量问题空间和解决方案空间。全息分析中重视"析"的方法和技术,具备更高层次的中药质量理解和设计整合功能。提出综合应用检验质量控制、统计质量控制、预测质量控制和智能质量控制实现中药产品质量一致性和工艺系统可靠性。全程优化致力于生命周期内的中药质量和过程能力改进。实施QbD有利于化解中药研发和制造生态系统内在矛盾,为中药质量和产业效益的提升提供保障。
|
| 关 键 词： | 质量源于设计 中药 设计思维 质量一致性 工艺系统可靠性 |
| 收稿时间： | 2017-01-08 |
Quality by design approaches for pharmaceutical development and manufacturing of Chinese medicine |
| |
| XU Bing,SHI Xin-yuan,WU Zhi-sheng,ZHANG Yan-ling,WANG Yun and QIAO Yan-jiang. Quality by design approaches for pharmaceutical development and manufacturing of Chinese medicine[J]. China Journal of Chinese Materia Medica, 2017, 42(6): 1015-1024 |
| |
| Authors: | XU Bing SHI Xin-yuan WU Zhi-sheng ZHANG Yan-ling WANG Yun QIAO Yan-jiang |
| |
| Affiliation: | Research Center of Traditional Chinese Medicine Information Engineering, Beijing University of Chinese Medicine, Beijing 100029, China;Beijing Key Laboratory for Production Process Control and Quality Evaluation of Traditional Chinese Medicine, Beijing Municipal Science & Technology Commission, Beijing 100029, China;Engineering Research Center of Key Technologies for Chinese Medicine Production and New Drug Development, Ministry of Education of People''s Republic of China, Beijing 100029, China,Research Center of Traditional Chinese Medicine Information Engineering, Beijing University of Chinese Medicine, Beijing 100029, China;Beijing Key Laboratory for Production Process Control and Quality Evaluation of Traditional Chinese Medicine, Beijing Municipal Science & Technology Commission, Beijing 100029, China;Engineering Research Center of Key Technologies for Chinese Medicine Production and New Drug Development, Ministry of Education of People''s Republic of China, Beijing 100029, China,Research Center of Traditional Chinese Medicine Information Engineering, Beijing University of Chinese Medicine, Beijing 100029, China;Beijing Key Laboratory for Production Process Control and Quality Evaluation of Traditional Chinese Medicine, Beijing Municipal Science & Technology Commission, Beijing 100029, China;Engineering Research Center of Key Technologies for Chinese Medicine Production and New Drug Development, Ministry of Education of People''s Republic of China, Beijing 100029, China,Research Center of Traditional Chinese Medicine Information Engineering, Beijing University of Chinese Medicine, Beijing 100029, China,Research Center of Traditional Chinese Medicine Information Engineering, Beijing University of Chinese Medicine, Beijing 100029, China and Research Center of Traditional Chinese Medicine Information Engineering, Beijing University of Chinese Medicine, Beijing 100029, China;Beijing Key Laboratory for Production Process Control and Quality Evaluation of Traditional Chinese Medicine, Beijing Municipal Science & Technology Commission, Beijing 100029, China;Engineering Research Center of Key Technologies for Chinese Medicine Production and New Drug Development, Ministry of Education of People''s Republic of China, Beijing 100029, China |
| |
| Abstract: | The pharmaceutical quality was built by design, formed in the manufacturing process and improved during the product''s lifecycle. Based on the comprehensive literature review of pharmaceutical quality by design (QbD), the essential ideas and implementation strategies of pharmaceutical QbD were interpreted. Considering the complex nature of Chinese medicine, the "4H" model was innovated and proposed for implementing QbD in pharmaceutical development and industrial manufacture of Chinese medicine product. "4H" corresponds to the acronym of holistic design, holistic information analysis, holistic quality control, and holistic process optimization, which is consistent with the holistic concept of Chinese medicine theory. The holistic design aims at constructing both the quality problem space from the patient requirement and the quality solution space from multidisciplinary knowledge. Holistic information analysis emphasizes understanding the quality pattern of Chinese medicine by integrating and mining multisource data and information at a relatively high level. The batch-to-batch quality consistence and manufacturing system reliability can be realized by comprehensive application of inspective quality control, statistical quality control, predictive quality control and intelligent quality control strategies. Holistic process optimization is to improve the product quality and process capability during the product lifecycle management. The implementation of QbD is useful to eliminate the ecosystem contradictions lying in the pharmaceutical development and manufacturing process of Chinese medicine product, and helps guarantee the cost effectiveness. |
| |
| Keywords: | quality by design (QbD) Chinese medicine design thinking quality consistence process system reliability |
| 本文献已被 CNKI 等数据库收录！ |
|
